Histamine modulates mast cell degranulation through an indirect mechanism in a model IgE-mediated reaction

European Journal of Immunology

Volumn 36, Issue 6, 2006, Pages 1494-1503

  Carlos, Daniela ^a   Sá Nunes, Anderson ^a   de Paula, Lucia ^a   Matias Peres, Camila ^a   Jamur, Maria Célia ^a   Oliver, Constance ^a   Serra, Magda Fraguas ^b   Martins, Marco Aurélio ^b   Faccioli, Lúcia Helena ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Histamine; IgE; Lymphocyte; Macrophage; Mast cell

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE; HISTAMINE; IMMUNOGLOBULIN E; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL POPULATION; CELL STIMULATION; CELL STRUCTURE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; MAST CELL DEGRANULATION; NONHUMAN; PARASITOSIS; PERITONEAL CAVITY; PERITONEUM MACROPHAGE; PERITONEUM MAST CELL; PRIORITY JOURNAL; PROTEIN SECRETION; PURIFICATION; RAT; SPLEEN CELL; SUPERNATANT; TOXOCARA CANIS;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; CELL DEGRANULATION; CIMETIDINE; FEMALE; FLOW CYTOMETRY; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MAST CELLS; NITRIC OXIDE; P-METHOXY-N-METHYLPHENETHYLAMINE; PERITONEAL CAVITY; PYRILAMINE; RATS; RATS, WISTAR; TOXOCARA CANIS; TOXOCARIASIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745482062     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535464     Document Type: Article

References (46)

1. Jutel, M., Klunker, S., Akdis, M., Malolepszy, J., Thomet, O. A. R., Zak-Nejmark, T., Blaser, K. et al., Histamine upregulates Th1 and down-regulates Th2 responses due to different patterns of surface histamine 1 and 2 receptor expression. Int. Arch. Allergy Immunol. 2001. 24: 190-192.
2. 2 receptors. Nature 2001. 413: 420-424.
3. László, V., Rothe, G., Hegyesi, H., Szeberényi, J. B., Orsó, E., Schmitz, G. and Falus, A., Increased histidine decarboxylase expression during in vitro monocyte maturation; a possible role of endogenously synthesised histamine in monocyte/macrophage differentiation. Inflamm. Res. 2001. 50: 428-434.
4. 1 receptors. J. Immunol. 2001. 166: 4083-4091.
5. Hirasawa, N., Ohtsu, H., Watanabe, T. and Ohuchi, K., Enhancement of neutrophil infiltration in histidine decarboxylase-deficient mice. Immunology 2002. 107: 217-221.
6. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br. J. Pharmacol. 2004. 142: 161-171.
7. Alam, R., Forsythe, P. A., Lett-Brown, M. A. and Grant J. A., Cellular origin of histamine-releasing factor produced by peripheral blood mono-nuclear cells. J. Immunol. 1989. 142: 3951-3956.
8. MacDonald, S. M., Lichtenstein, L. M., Proud, D., Plant, M., Naclerio, R. M., MacGlashan, D. W. and Kagey-Sobotka, A., Studies of IgE-dependent histamine-releasing factors: Heterogeneity of IgE. J. Immunol. 1987 139: 506-512.
9. Siraganian, R. P., Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opinion Immunol. 2003. 15: 639-646.
10. Church, M. K. and Levi-Schaffer, F., The human mast cell. J. Allergy Clin. Immunol. 1997. 99: 155-160.
11. Kitaura, J., Song, J., Tsai, M., Asai K., Maeda-Yamamoto, M., Mocsai, A. and Kawakami, Y., Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc. Natl. Acad. Sci. USA 2003. 100: 12911-12916.
12. Else, K. J. and Finkelman, F. D., Intestinal nematode parasites, cytokines and effector mechanisms. Int. J. Parasitol. 1998. 28: 1145-1158.
13. Pinelli, E., Dormans, J., Fonville, M. and Van Der Giessen, J., A comparative study of toxocariasis and allergic asthma in murine models. J. Helminthol. 2001. 75: 137-140.
14. Bidri, M., Féger, F., Varadaradjalou, S., Hamouda, N. B., Guillosson, J. J. and Arock, M., Mast cells as a source and target for nitric oxide. Int. Immunopharmacol. 2001. 1: 1543-1558.
15. Al-Naemi H. and Baldwin, A. L., Nitric oxide: Role in venular permeability recovery alter histamine challenge. Am. J. Physiol. 1999. 277: H2010-H2016.
16. Orr, T. S. C., Pollard, M. C., Gwillian, J. and Cox, J. S. G., Mode of action of disodium cromoglycate, studies on immediate type hypersensitivity reaction using 'double sensibilization with two antigenically distinct rat reagins. Clin. Exp. Immunol. 1970. 7: 745-757,
17. Sá-Nunes, A., Corrado, A. P., Baruffi, M. D. and Faccioli, L. H., Disodium cromoglycate prevents ileum hyperreativity to histamine in Toxocara canis-infected guinea pigs. Pharmacol. Res. 2003. 48: 451-455.
18. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 2003. 305: 1212-1221.
19. Yanni, J. M., Miller, S. T., Gamache, D. A., Spellman, J. M., Xu, S., Sharif, N. A., Comparative effects of topical ocular anti-allergic drugs on human conjunctival mast cells. Ann. Allergy Asth. Immunol. 1997 79: 541-545.
20. Sharif, N. A., Xu, S., Miller, S. T., Gamache, D. A., Yanni J. M., Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J. Pharmacol. Exp. Therap. 1996. 278: 1252-1261.
21. Grant, J. A., Alam, R., Lett-Brown, M. A., Histamine-releasing factors and inhibitors: Historical perspectives and possible implications in human illness. J. Allergy Clin. Immunol. 1991. 88: 683-693.
22. Kuna, P. and Kaplan, A.P., Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine. Allergy Asthma Proc. 1996. 17: 5-11.
23. Alam, R., Kumar, D., Anderson-Walters, D., Forsythe, P. A., Macrophage inflammatory protein-1α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J. Immunol. 1994. 152: 1298-1303.
24. Levi-Schaffer, F., Segal, V. and Shalit, M., Effect of interleukins on connective tissue type mast cells co-cultured with fibroblasts. Immunology 1991. 223: 171-177.
25. Nomura, H., Sato, E., Koyama, S., Haniuda, M., Kubo, K., Nagai S. and Izumi T., Histamine stimulates alveolar macrophages to release neutrophil and monocyte chemotactic activity. J. Lab. Clin. Med. 2001. 138: 226-235.
26. Bachert, C., The role of histamine in allergic disease: Re-appraisal of its inflammatory potential. Allergy 2002. 57: 287-296.
27. 3-receptors in the regulation of anaphylactic histamine release from isolated rat peritoneal mast cells. Jpn. J. Pharmacol. 1994. 66: 173-180.
28. Akdis, C. A. and Blaser, K., Histamine in the immune regulation of allergic inflammation. J. Allergy Clin. Immunol. 2003. 112: 15-22.
29. Jutel, M., Blaser, K. and Akdis, C. A., Histamine in allergic inflammation and immune modulation. Int. Arch. Allergy Immunol 2005. 137: 82-92.
30. Alam, R., Rozniecki, J. and Kuzminska, B. A., A mononuclear cell-derived histamine releasing factor (HRF) in asthmatic patients. Ann. Allergy 1985. 55: 825-829.
31. Alam, R., Kuna, P., Rozniecki, J. and Kuzminska, B. A., Bacterial antigens stimulate the production of histamine releasing factor (HRF) by lymphocytes from intrinsic asthmatic patients. Clin. Exp. Immunol. 1986. 63: 241-248.
32. Bhattacharyya, S. P., Drucker, I, Reshef, T., Kirshenbaum, A. S., Mekori, D. D. and Mekori, Y. A., Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-cell contact. J. Leuk. Biol. 1998. 63: 337-341.
33. Mekori, Y. A. and Metcalfe, D. D., Mast cell-T cell interactions. J. Allergy Clin. Immunol. 1999. 104: 517-523.
34. Shulman. E. S., Liu, M. C., Proud, D., Macglashan, D. W. J., Lichtenstein, L. M. and Plaut, M., Human lung macrophages induce histamine release from basophils and mast cells. Am. Rev. Respir. Dis. 1985. 131: 230-235.
35. 3 receptors. Am. J. Respir. Cell Mol. Biol. 1996. 14:620-626.
36. Yamaguchi, M., Lantz, C. S., Oettgen, H. C., Katona, I. M., Fleming, T., Miyajima, I., Kinet, J.-P. et al., IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions. J. Exp. Med. 1997. 17: 663-672.
37. Coleman, J. W., Nitric oxide: A regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 2002. 129: 4-10.
38. Olson, L. J. and Schultz, C. W., Nematode induced hypersensitivity reactions in guinea pigs: Onset of eosinophilia and positive Schultz-Dale reactions following graded infection with Toxocara canis. Ann. N. Y. Acad. Sci. 1963. 113: 440-455.
39. Faccioli, I. H., Mokwa, V. F., Silva, C. L., Rocha, G. M., Araújo, J. I., Nahori, M. A. and Vargaftig, B. B., IL-5 drives eosinophils from bone marrow to blood and times in a guinea-pig model of visceral larva migrans syndrome. Mediators Inflamm. 1996. 15: 24-31.
40. Yeoh, T. S., Yap, E. H., Singh, M. and Ho, B. C., Drug inhibition of anaphylactic histamine release from peritoneal cells of rats infected with Toxocara canis. Int. Arch. Allergy Appl. Immun. 1975. 49: 371-380.
41. Mendonga, V. O., Vugman, I. and Jamur, M. C., Maturation of adult rat peritoneal and mesenteric mas cells: A morphological and histofluorescence study. Cell. Tissue Res. 1986. 243: 635-639.
42. Jamur, M. C., Grodzki, A. C. G., Moreno, A. N., Swaim W. D., Siraganian, R. P. and Oliver, C., Immunomagnetic isolation of rat bone marrow derived and peritoneal mast cells. J. Histochem. Cytochem. 1997. 45: 1715-1722.
43. Jamur, M. C., Grodzki, A. C. G., Berenstein, E. H., Hamawy, M. M., Siraganian, R. P. and Oliver, C., Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood 2005. 105: 4282-4289.
44. Rees, G. S., Gee, C. K., Ward, H. L., Ball, C., Tarrant, G. M., Poole, S. and Bristow, A. F., Rat tumour necrosis factor-alpha: Expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA. Eur. Cytokine Network 1999. 10: 383-392.
45. 14N] nitrite in biological fluids. Anal. Biochem. 1982. 126: 131-138.
46. Bazin, H., Cormont, F. and De Clererq, L., Rat monoclonal antibodies. II. A rapid and efficient method for purification from ascitic fluid or serum. J. Immunol. Methods 1984. 71: 9-16.